FICO, EHang, and Caris Life Sciences announced major share repurchase programs to enhance shareholder value. FICO (Fair Isaac Corporation) increased its authorization to $2 billion, securing a $1.5 billion term loan to fund an accelerated stock repurchase agreement. Meanwhile, EHang launched a $30 million program, and Caris Life Sciences authorized the buyback of up to $100 million of its common stock.
